57 / 86
The recommended dose of eribulin as the ready to use solution is
1.23mg/m
2
on Days 1 and 8 of every 21-day cycle
1
Eribulin is Simple and Quick to Administer
1. Eisai Europe Limited. Halaven: Summary of Product Characteristics. March 2011
2. Cortes J, O’Shaughnessy J et al.
Lancet
. 2011;377:914–923
Eribulin is administered intravenously;
the recommended duration of
administration is over 2–5 minutes
1
There is no evidence that eribulin is a vesicant
1
The eribulin solution does not contain solubilising agents
Pre-medication to prevent solubilising agent-induced hypersensitivity reactions is not
required
2
Eribulin is considered to be an CT agent of low emetogenic potential